S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
NASDAQ:BIS

ProShares UltraShort Nasdaq Biotechnology (BIS) Price, Holdings, & News

$17.58
+0.14 (+0.80%)
(As of 03/28/2024 ET)
Today's Range
$17.32
$17.58
50-Day Range
$16.46
$18.68
52-Week Range
$16.37
$26.51
Volume
2,497 shs
Average Volume
24,633 shs
Market Capitalization
$8.26 million
Assets Under Management
$3.00 million
Dividend Yield
2.67%
Net Expense Ratio
0.95%
BIS stock logo

About ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in equity securities and derivatives that have similar daily performance characteristics as twice (200%) the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.

BIS Stock Price History

BIS ETF News Headlines

ProShares UltraShort Nasdaq Biotechnology (BIS)
This consistently signaled gains of 453%... 610%... and even 1036%...
It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.
ProFunds UltraShort NASDAQ-100 Svc
ProFunds UltraShort NASDAQ-100 Inv
Claim Your Complimentary Bitcoin Reward
Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.
NASDAQ Biotechnology Index .NBI : NASDAQ
See More Headlines
Receive BIS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ProShares UltraShort Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
ProShares
Fund Name
ProShares UltraShort Nasdaq Biotechnology
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:BIS
Inception Date
4/6/2010
Fund Manager
Michael Neches, Tarak Dave

Fund Focus

Asset Class
Equity
Benchmark
Nasdaq Biotech Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
15

Fund Statistics

Assets Under Management
$3.00 million
Average Daily Volume
$7,922.90
Discount/Premium
0.03%
Leveraged
-2.00

Administrator, Advisor and Custodian

Administrator
J.P. Morgan Investor Services Co.
Advisor
ProShare Advisors LLC
Custodian
JPMorgan Chase Bank, N.A.
Distributor
SEI Investments Distribution Co.
Transfer Agent
JPMorgan Chase Bank, N.A.
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
16
Put Options
1
Call Options
15
Short Interest
7,900 shs

Miscellaneous

Beta
-1.41
Creation Unit
50,000
Creation Fee
$250.00
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

ProShares UltraShort Nasdaq Biotechnology Expenses

TypeBISHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.75%0.57%0.54%0.48%0.51%
Other Expenses0.80%0.40%0.54%0.32%0.58%
Total Expense1.55%0.72%0.70%0.57%0.70%
Fee Waiver-0.60%-0.53%-0.54%-0.20%-0.56%
Net Expense0.95%0.61%0.60%0.54%0.58%

ProShares UltraShort Nasdaq Biotechnology (BIS) Holdings

Top 7 BIS Holdings

  • NET OTHER ASSETS (LIABILITIES)
    Holding Weight: 0.00%
  • NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG
    Holding Weight: -4.40%
  • NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC
    Holding Weight: -20.60%
  • NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA
    Holding Weight: -30.11%
  • NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA
    Holding Weight: -31.76%
  • NASDAQ BIO INDEX SWAP BNP
    Holding Weight: -34.51%
  • NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE
    Holding Weight: -78.77%

BIS ETF - Frequently Asked Questions

How have BIS shares performed in 2024?

ProShares UltraShort Nasdaq Biotechnology's stock was trading at $18.07 at the beginning of the year. Since then, BIS shares have decreased by 2.7% and is now trading at $17.58.
View the best growth stocks for 2024 here
.

How often does ProShares UltraShort Nasdaq Biotechnology pay dividends? What is the dividend yield for ProShares UltraShort Nasdaq Biotechnology?

ProShares UltraShort Nasdaq Biotechnology declared a dividend on Tuesday, March 19th. Stockholders of record on Thursday, March 21st will be paid a dividend of $0.1586 per share on Wednesday, March 27th. The ex-dividend date is Wednesday, March 20th.
Read our dividend analysis for BIS
.

What does BIS invest in?

ProShares UltraShort Nasdaq Biotechnology is a equity fund issued by ProShares. BIS focuses on health care investments and follows the Nasdaq Biotech Index. The fund's investments total to approximately $2.98 million assets under management.

What is the management fee for ProShares UltraShort Nasdaq Biotechnology?

ProShares UltraShort Nasdaq Biotechnology's management fee is 0.75% and has other expenses of 0.80%. However, BIS has a fee waiver of -0.60% to reimburse the expenses. The net expense ratio for BIS is 0.95%.

When did ProShares UltraShort Nasdaq Biotechnology's stock split?

ProShares UltraShort Nasdaq Biotechnology shares reverse split on Tuesday, August 18th 2020. The 1-4 reverse split was announced on Tuesday, August 4th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 17th 2020. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

What other stocks do shareholders of ProShares UltraShort Nasdaq Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares UltraShort Nasdaq Biotechnology investors own include Inovio Pharmaceuticals (INO), Gilead Sciences (GILD), Intel (INTC), Quest Diagnostics (DGX), Micron Technology (MU), Pfizer (PFE), Cidara Therapeutics (CDTX) and Vertex Pharmaceuticals (VRTX).

Who are ProShares UltraShort Nasdaq Biotechnology's major shareholders?

ProShares UltraShort Nasdaq Biotechnology's stock is owned by many different institutional and retail investors. Top institutional investors include IMC Chicago LLC (3.19%), Tower Research Capital LLC TRC (1.00%) and Citadel Advisors LLC (0.00%).
View institutional ownership trends
.

How do I buy shares of ProShares UltraShort Nasdaq Biotechnology?

Shares of BIS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BIS) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners